Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. - Wikidata - thesis-toulmin - TriplyDB

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

http://www.wikidata.org/entity/Q45376159

about

Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines Hepatitis B Management in the Pregnant Patient: An Update Recent advances in understanding and diagnosing hepatitis B virus infection Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature Immune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DP Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.Clinical utility of hepatitis B surface antigen levels during the natural history and treatment of chronic hepatitis B infection Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs.Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection.High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.Comparison of three luminescent immunoassays for hepatitis B virus surface antigen quantification during the natural history of chronic hepatitis B virus infection.Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.Viral hepatitis B: clinical and epidemiological characteristics.HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.Evaluation of changes of serum hepatitis B surface antigen from a different perspective.Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV.Management of hepatitis B in developing countries.Hepatitis B virus genotypes and variants.Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment.Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study.Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.Serum hepatitis B surface antigen levels and their utility as a predictor of sustained virological response after antiviral treatment.Elimination of Hepatitis B: Is It a Mission Possible?Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a Virus and Host Testing to Manage Chronic Hepatitis B.Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Histological grading and staging of liver and its relation to viral loads in chronic anti-HBe positive hepatitis.Evaluation of the need for treatment on 72 subjects with anti-HBe positive chronic hepatitis B.Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B.New perspectives of biomarkers for the management of chronic hepatitis B.

P2860

Q26995814-BB4436E7-8B57-4EF3-9DE9-80972F2BD838 Q27000080-B415F0AA-00AF-4DE3-98A9-9BA0D1815F38 Q28066219-3C146466-8A08-43B3-B79E-F3F311F59265 Q28067419-2515BEE7-463D-4AEF-BBCC-F06897EC00E9 Q28080109-DAC48685-1528-4CCB-9CB2-472051482BB4 Q28086834-F25C3CF4-B7D7-49F3-AA95-7767CD56F4DB Q30220690-EF1C1B5D-4BCA-4649-B534-E528813819C5 Q33801305-4271A3D2-1716-44C3-9DE9-D420DAED3855 Q33947471-FAACE53D-6783-423C-B429-7F65CAAAD669 Q34168465-1F1BB728-063E-428F-9518-826B7E805F14 Q34189348-01327FD5-C0B4-4E93-84A0-618D41778916 Q34217300-6047E5FA-AEEF-4E2A-BB11-BD69E22B3052 Q34384793-569DF675-60C3-43C4-8A74-034A46217A78 Q34391308-D1A11D04-EE5D-4020-8B76-A3469626F852 Q34414722-79734ED4-FB1F-4DCD-8487-D25971153E9F Q34592952-A20D8C1B-420F-4D14-BDAF-99CF1B11CDE1 Q34598267-1A47BF8A-02B2-4865-BCA4-89AB9C7A60B2 Q34764269-1B6DA48B-2BA8-4F77-A96A-5F7C38D52283 Q34930389-3566CFD0-BC8F-4672-97DF-1029B20ADE10 Q34998266-1B1D15D5-80DD-44EF-86E6-144B7A5E668D Q35152364-7E77EB6B-4BB0-40A4-987F-54397CACB81E Q35402699-D3858469-78A2-44C5-B270-5A55CB351991 Q35540204-1227BDFD-6458-4A4C-9476-070B5640F14B Q35635637-95B6E369-D855-47C9-804C-FCF49FAD38E2 Q35663838-D150F909-87FF-498D-93F0-E91712F963CC Q35675909-900C66C0-4F6E-4AB5-8415-DC9840D38648 Q35746110-22D06F05-7915-4E4C-8B6C-142106D6D902 Q35876187-C7E08378-AA1F-4330-A83A-3050A6C630DE Q35942365-EA4FCF62-B9FA-4913-81A6-9CDA7F8F7EC1 Q36151658-796D531A-E5CD-4493-AF9B-83F2CFB0AEFE Q36217581-24A797D6-DEA7-4C9B-B25A-0F3B18C96CAC Q36220194-48138DCE-B66A-475B-A2B1-DBA753B45501 Q36307834-62819793-4E97-4BB3-A73E-F1671A47EE72 Q36924978-B4BEC392-CC37-40EF-A16E-1002576B7CAC Q36958940-3A003A73-F1F5-4DED-B7B6-7CC69F341BA1 Q36973383-46D62A5C-7129-4E45-A4A7-D131D03C4906 Q37128478-65FBF671-69A8-43E4-9CC5-5157CF2C9F9B Q37128552-FFFE5AF4-71A8-47B9-834C-B5D06005F56A Q37343296-1E157A54-3AB6-41E5-AAA4-C069992D1CFB Q37606546-7363669F-B157-4F80-B1B9-E884DA15839C

P2860

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

http://www.wikidata.org/entity/Q45376159

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Hepatitis B surface antigen se ...... s B virus genotype D carriers.

@en

Hepatitis B surface antigen se ...... s B virus genotype D carriers.

@nl

type

label

Hepatitis B surface antigen se ...... s B virus genotype D carriers.

@en

Hepatitis B surface antigen se ...... s B virus genotype D carriers.

@nl

prefLabel

Hepatitis B surface antigen se ...... s B virus genotype D carriers.

@en

Hepatitis B surface antigen se ...... s B virus genotype D carriers.

@nl

P1433

Q45376159-83EB8D9A-7A84-4F5E-B415-7ACA8B2E6285

P1476

Q45376159-0F02BA37-927D-4FF9-B306-D4A9F5351B47

P2093

Q45376159-1B9891F0-C0B5-448E-BFEF-EE00E30F43C0

Q45376159-23D175C1-F585-49C6-A33C-61341ABA5C99

Q45376159-7A7682FD-6AAB-4001-9DF8-4C34ED625F2F

Q45376159-87B8EE0A-96B0-4A85-BB41-203521B34C69

Q45376159-94216468-C5FC-4E71-AB78-6E8BEE53D434

Q45376159-A85739F8-F16E-401B-9EF8-6E28052271FB

Q45376159-C56CF825-CC99-4CD7-AA01-8F445809C694

Q45376159-DE7E08A4-646B-4255-B5BF-C33DB6B3B19A

P304

Q45376159-6615F0B9-83F5-4820-ACFC-ABC84DAAC5DD

P31

Q45376159-920312D6-FB1F-48AB-9C54-AADD994F45C3

P356

Q45376159-CAA7F246-8F57-420B-960E-5A069229AC12

P407

Q45376159-D7C9238E-ECE8-46D5-9D06-7DF641AB60C4

P433

Q45376159-52938523-B9EC-4F9C-B4CD-033D3FB16F2C

P478

Q45376159-2FA5E6EA-7423-4D7A-9E83-4E2947BD8312

P50

Q45376159-37965D06-6F3B-421E-B6D6-96DF7DBE7DA2

Q45376159-60E8507E-0802-41AB-AE91-5FBB95487931

Q45376159-7CA5C542-9E6F-4052-84D5-1C771318CF91

Q45376159-E242DC7B-AF1A-4D8E-88A8-881206725E4A

P577

Q45376159-6D40E181-3E1D-4814-9135-0FBEFEC2D57A

P698

Q45376159-93E7EA82-FDB7-4D09-BF6A-94B16B357EEA

P356

J.GASTRO.2010.04.052

P1433

Gastroenterology

P1476

Hepatitis B surface antigen se ...... is B virus genotype D carriers

@en

P2093

Anna Maria Maina

http://www.w3.org/2001/XMLSchema#string

Barbara Coco

http://www.w3.org/2001/XMLSchema#string

Beatrice Cherubini

http://www.w3.org/2001/XMLSchema#string

Daniela Cavallone

http://www.w3.org/2001/XMLSchema#string

Francesco Moriconi

http://www.w3.org/2001/XMLSchema#string

Giovanna Moscato

http://www.w3.org/2001/XMLSchema#string

Pietro Ciccorossi

http://www.w3.org/2001/XMLSchema#string

Veronica Romagnoli

http://www.w3.org/2001/XMLSchema#string

P304

483-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2010.04.052

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Ferruccio Bonino

Piero Colombatto

Maurizia R Brunetto

P577

2010-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20451520

http://www.w3.org/2001/XMLSchema#string